Drug Shortage Report for KEVZARA
| Report ID | 181429 |
| Drug Identification Number | 02472961 |
| Brand name | KEVZARA |
| Common or Proper name | Kevzara 150 |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SARILUMAB |
| Strength(s) | 150MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2 |
| ATC code | L04AC |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-01-17 |
| Estimated end date | 2023-03-15 |
| Actual end date | 2023-03-14 |
| Shortage status | Resolved |
| Updated date | 2023-03-15 |
| Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-03-15 | English | Compare |
| v4 | 2023-01-18 | French | Compare |
| v3 | 2023-01-18 | English | Compare |
| v2 | 2023-01-18 | French | Compare |
| v1 | 2023-01-18 | English | Compare |
Showing 1 to 5 of 5